NCT04195906: A trial that was reported late by Sanifit Therapeutics S. A.
This trial has reported, although it was 22 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04195906 |
|---|---|
| Title | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 12, 2020 |
| Completion date | Oct. 24, 2022 |
| Required reporting date | Oct. 24, 2023, midnight |
| Actual reporting date | Nov. 15, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 22 |